Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study.
Gemelli M, Elli EM, Elena C, Iurlo A, Intermesoli T, Maffioli M, Pungolino E, Carraro MC, D'Adda M, Lunghi F, Anghileri M, Polverelli N, Rossi M, Bacciocchi M, Bono E, Bucelli C, Passamonti F, Antolini L, Gambacorti-Passerini C.
Gemelli M, et al. Among authors: bacciocchi m.
Blood Res. 2020 Sep 30;55(3):139-145. doi: 10.5045/br.2020.2020130.
Blood Res. 2020.
PMID: 32792470
Free PMC article.